Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling (Q38104143)

28 August 2017

Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling (English)

1 reference

28 August 2017

3

1 reference

28 August 2017

Olalla Iglesias-García

series ordinal

1

1 reference

PubMed ID

23643470

28 August 2017

Beatriz Pelacho

series ordinal

2

1 reference

28 August 2017

30 April 2013

1 reference

Journal of Molecular and Cellular Cardiology

28 August 2017

1 reference

28 August 2017

62

1 reference

28 August 2017

43-50

1 reference

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

28 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Stem-cell-based therapy and lessons from the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Adult cardiac stem cells are multipotent and support myocardial regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Mammalian heart renewal by pre-existing cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induced pluripotent stem cell lines derived from human somatic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induced pluripotency: history, mechanisms, and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

The promise of induced pluripotent stem cells in research and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Generation of germline-competent induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Embryo-derived stem cells: of mice and men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

MicroRNA profiling of human-induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Transcriptional signature and memory retention of human-induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Immunogenicity of induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induced pluripotent stem cells: developmental biology to regenerative medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Generation of functional murine cardiac myocytes from induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induction and isolation of vascular cells from human induced pluripotent stem cells--brief report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Fibroblast growth factor-10 promotes cardiomyocyte differentiation from embryonic and induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Stage-specific role of endogenous Smad2 activation in cardiomyogenesis of embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Notch inhibition promotes human embryonic stem cell-derived cardiac mesoderm differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Cardiac repair with thymosin β4 and cardiac reprogramming factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Heart repair by reprogramming non-myocytes with cardiac transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Biomaterials for the treatment of myocardial infarction: a 5-year update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Creation of human cardiac cell sheets using pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Growth of engineered human myocardium with mechanical loading and vascular coculture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Induced pluripotent stem cells: the new patient?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Patient-specific induced pluripotent stem-cell models for long-QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Modelling the long QT syndrome with induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.04.022

10.1016/J.YJMCC.2013.04.022

7 January 2021

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23643470